CVE-2020-27272

Description

SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and AnyDana-i,AnyDana-A mobile apps doesn't use adequate measures to authenticate the pump before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the keys and spoof the pump via BLE.

5.7

CVSS

Severity: Medium

CVSS 3.1 •

CVSS 2.0 •

EPSS 0.09%

Third-Party Advisory cisa.gov

Affected: n/a SOOIL Developments CoLtd DiabecareRS,AnyDana-i,AnyDana-A

References

Link	Tags
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01	third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2020-27272?: CVE-2020-27272 has been scored as a medium severity vulnerability.
How to fix CVE-2020-27272?: To fix CVE-2020-27272, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-27272 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2020-27272 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-27272?: CVE-2020-27272 affects n/a SOOIL Developments CoLtd DiabecareRS,AnyDana-i,AnyDana-A.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.